Published in Neurobiol Dis on November 13, 2014
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79
Alzheimer's disease is a synaptic failure. Science (2002) 13.82
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem (2004) 5.14
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron (2004) 3.21
Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol (2012) 3.03
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol (2007) 2.30
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis (2006) 2.00
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med (2013) 1.96
Neuronal pentraxins mediate synaptic refinement in the developing visual system. J Neurosci (2006) 1.71
Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. Neuron (2003) 1.58
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement (2014) 1.56
A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One (2011) 1.55
Interaction of the N-terminal domain of the AMPA receptor GluR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment. Neuron (2007) 1.45
Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol (2013) 1.32
mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE. Neuron (2008) 1.31
Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation (2012) 1.31
Plasma tau levels in Alzheimer's disease. Alzheimers Res Ther (2013) 1.30
Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J Biol Chem (2000) 1.22
Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS One (2009) 1.19
Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxin-associated calcium-binding protein 49. J Biol Chem (1997) 1.12
TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal (2012) 1.11
Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics (2014) 1.10
A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis (2008) 1.09
A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Neurobiol Aging (2007) 1.08
Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci (2007) 1.06
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases. Brain Res (2009) 1.04
Neuronal pentraxins mediate silent synapse conversion in the developing visual system. J Neurosci (2010) 1.03
Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma. Brain Inj (2013) 1.01
Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci (2013) 0.99
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Arch Neurol (2012) 0.97
Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. J Neurosci (2006) 0.96
Monoclonal antibody to the C-terminus of beta-amyloid. Neuroreport (1994) 0.95
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease. Proteomics Clin Appl (2007) 0.94
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurol Scand Suppl (2012) 0.93
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics. Mol Neurodegener (2014) 0.93
Regulation of neuronal type genes in congestive heart failure rats. Acta Physiol (Oxf) (2006) 0.92
Mechanisms of memory loss in Abeta and tau mouse models. Biochem Soc Trans (2005) 0.92
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol (2011) 0.90
Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Neurochem Int (2007) 0.90
DNA array reveals altered gene expression in response to focal cerebral ischemia. Brain Res Bull (2002) 0.88
Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse (2009) 0.88
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment. Neurobiol Dis (2011) 0.85
Early impairment of long-term depression in the perirhinal cortex of a mouse model of Alzheimer's disease. Rejuvenation Res (2012) 0.84
In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP/PS1 mice. J Neurosci Res (2014) 0.78
Creation of a federated database of blood proteins: a powerful new tool for finding and characterizing biomarkers in serum. Clin Proteomics (2014) 0.76